Results 21 to 30 of about 3,398 (179)

Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency. [PDF]

, 2009
Background: Iron deficiency may impair aerobic performance. This study aimed to determine whether treatment with intravenous iron (ferric carboxymaltose) would improve symptoms in patients who had heart failure, reduced left ventricular ejection fraction,
Drexler, Helmut, Rothe, Willenheimer, Ronnie, Mori, Claudio, Comin Colet, Josep, Filippatos, Gerasimos, Anker, Stefan D., Ponikowski, Piotr, Barbara von Eisenhart, FAIR-HF Trial Investigators, Niegowska, Joanna, Bart, Boris, Kirwan, Bridget-Anne, Banasiak, Waldemar, Pocock, Stuart J., Dickstein, Kenneth, Poole-Wilson, Philip A., Luescher, Thomas F.   +17 more
core   +2 more sources

Treatment of iron deficiency with intravenous ferric carboxymaltose in general practice: a retrospective database study. [PDF]

, 2015
BACKGROUND Iron deficiency is a frequent problem in general practice. Oral supplementation may in some cases not be well tolerated or not be efficient.
Kuster, Martina, Meli, Damian N
core   +1 more source

Impact of iron replacement therapy on six minutes walking test (functional state) in patients with heart failure with reduced ejection fraction and iron deficiency

Zanco Journal of Medical Sciences, 2022
Background and objective: Iron deficiency may impair aerobic performance. This study aimed to assess whether intravenous iron (ferric carboxymaltose) will improve symptoms in patients with heart failure with reduced left ventricular ejection fraction and
Hemn Ahmed Ismael, Mudhafar Abdulrahman Habeeb   +1 more
doaj   +1 more source

Role of Intravenous Ferric Carboxy-maltose in Pregnant Women with Iron Deficiency Anaemia

Journal of Nepal Health Research Council, 2017
Background: Iron deficiency is a common nutritional deficiency amongst women of childbearing age. Peri-partum iron deficiency anaemia is associated with significant maternal, foetal and infant morbidity.
Vineet Mishra, Khusaili Gandhi, Priyankur Roy, Shaheen Hokabaj, Kunur N Shah   +4 more
doaj   +1 more source

A rare case of parental iron-induced persistent hypophosphatemia

Journal of Community Hospital Internal Medicine Perspectives, 2020
We report a case of an African American woman who presented with fatigue, generalized weakness, and hypophosphatemia in the setting of a recent hospitalization for severe, symptomatic iron deficiency anemia requiring ferric carboxymaltose infusions ...
Abigayle Sullivan, Theresa Lanham, Adam Rubin   +2 more
doaj   +1 more source

Adverse Reactions of Ferric Carboxymaltose [PDF]

Journal of Clinical and Diagnostic Research, 2014
The author reports a 55-year-old female diagnosed of chronic kidney disease grade-5 with associated co-morbidities like type 2 diabetes mellitus, diabetic retinopathy and hypothyroidism was admitted for arteriovenous fistula construction.
HARISH THANUSUBRAMANIAN, NAVIN PATIL, SMITA SHENOY, K L BAIRY, YASHDEEP SARMA   +4 more
doaj   +1 more source

To evaluate the efficacy and safety of intravenous ferrous carboxymaltose compared with Iron sucrose in treating iron deficiency anemia in postpartum period

Asian Journal of Medical Sciences, 2022
Background: Iron deficiency anemia continues to be a serious problem in developing countries resulting in spectrum of adverse events in pregnant women. The first choice for prophylaxis and treatment of mild IDA in pregnancy is oral iron therapy. However,
Akriti Gupta , Ashkrit Gupta , Uttara Gupta , Anand Gupta   +3 more
doaj   +1 more source

A hospital based study to access the usefulness of using the combination regime of the ferric carboxy maltose, vitamin B12 and folic acid as a treatment of severe anemia among pregnant women in a rural tribal community of South Gujarat

Indian Journal of Community Medicine, 2022
Introduction: Anemia is most common morbidity in pregnancy and micronutrient deficiency is its most common cause in India. Objective: It is to assess the beneficiary effects as well as side effects of single parenteral administration of ferric ...
Vayeda Maitri, Desai Tushar, Modi Dhiren, Desai Shrey, Desai Gayatri   +4 more
doaj   +1 more source

Hypophosphatemia\ua0is common after intravenous ferric carboxymaltose infusion among patients with symptomatic heart failure with reduced ejection fraction

, 2020
Administration of intravenous ferric carboxymaltose (FCM) for iron-deficient patients suffering heart failure with reduced ejection fraction (HFrEF) has been associated with transient hypophosphatemia.
Hay, Karen, Yee Weng Wong, Laher, Shaaheen, Alexander Dashwood, Fiona Chui, Shaaheen Laher, Vale, Cassandra, Chui, Fiona, Karen Hay, Wong, Yee Weng, Dashwood, Alexander, Cassandra Vale   +11 more
core   +1 more source

Ferric carboxymaltose with or without erythropoietin for the prevention of red-cell transfusions in the perioperative period of osteoporotic hip fractures: a randomized contolled trial. The PAHFRAC-01 project

BMC Musculoskeletal Disorders, 2012
Background Around one third to one half of patients with hip fractures require red-cell pack transfusion. The increasing incidence of hip fracture has also raised the need for this scarce resource. Additionally, red-cell pack transfusions are not without
Bernabeu-Wittel Máximo, Aparicio Reyes, Romero Manuel, Murcia-Zaragoza José, Monte-Secades Rafael, Rosso Clara, Montero Abelardo, Ruiz-Cantero Alberto, Melero-Bascones María   +8 more
doaj   +1 more source